In an effort to keep heart failure complications under check, Fortis Malar has been tirelessly striving to bring better heart care to the country. Along with performing path-breaking surgeries, our team of experts at Fortis Malar has also been constantly introducing world-class heart management methods to India. Today, we offer comprehensive solutions to advanced heart failure conditions all under one roof.

In addition to cutting-edge Ventricular Assist Device (VAD) therapy, the Fortis Centre for Heart Failure and Transplant has changed the way heart patients are treated today. The centre offers outpatient ambulatory therapy for administration of inotropic medications which helps in rapidly improving symptoms and restoring vital organs to their normal conditions.


Heart Transplant Programme: Since 2010, heart transplants have been regularly performed at Fortis Malar Hospital. And today our centre is internationally recognized benefitting patients with end-stage heart failure across the globe. We also focus on stabilization of patients as they await donor heart and alternative options for patients who are not candidates for transplant.

Ventricular Assist Devices (VADs): Pioneer in LVAD implant as permanent therapy in India, our doctors have a vast experience with VADs implant as a bridge to transplant and as a permanent support for patients who are not candidates for heart transplant.


Qualified electrophysiologists at our centre provide Cardiac Resynchronisation Therapy (CRT) with biventricular pacemakers and avoid life-threatening heart rhythm disorders with Implantable Cardioverter Defibrillators (ICDs).


Our expert team medically manages heart failure in patients with the latest available medications to control the progression of the condition, keeping patients out of the hospital, and reducing mortality. Also, the cardiac rehabilitation team counsels the patients and their family members on diet and other lifestyle modifications to limit symptoms and to optimise the patient’s ability to participate in daily routines.


ECMO offers new rays of hope to patients with devastating lung injury or heart failure. Using this technology in early stages also helps saving tissue from further hypoxic injury. Unlike an ordinary heart-lung bypass machine, ECMO can be used for days. Thus ECMO not only allows the heart and lungs to recover, but also offers patients some time for heart transplant i.e. can be used as ‘Bridge-To-Transplant or LVAD implant’.